Rethinking Clinical Trials

AUGUST 22, 2022

COVID-19, COVID-OUT. The COVID-OUT Trial is a remotely delivered, Phase 3, de-centralized clinical trial at 6 participating institutions to see if Ivermectin, Metformin or Fluvoxamine would prevent severe COVID-19. Learn more about COVID-OUT. University of Minnesota School of Public Health.

Trials 130

Trials Clinical Trials Clinical Trials Insulin 130

The Pharma Data

DECEMBER 3, 2020

The Phase 1 trial was a randomized, observer-blind, placebo-controlled study to assess the safety, reactogenicity and immunogenicity of the adjuvanted COVID-19 S-Trimer vaccine candidates formulated with different antigen levels. The manuscript describing the detailed results will be accessible on an online preprint server shortly.

Vaccination 52

Vaccination Vaccine Immune Response Protein 52

The Pharma Data

JANUARY 31, 2021

Clover plans to initiate a global Phase 2/3 efficacy trial of its protein-based S-Trimer COVID-19 vaccine candidate adjuvanted with Dynavax’s CpG 1018 plus alum in the first half of 2021 with an interim analysis for vaccine efficacy potentially in the middle of 2021. EMERYVILLE, Calif. and CHENGDU, China , Feb.

Vaccination 52

Vaccination Vaccine Trials Protein 52

Rethinking Clinical Trials

JULY 19, 2023

Key study limitations were the need for remote delivery due to the COVID-19 pandemic and the lack of total representation of the broader U.S. or international population across the selected sites and patients. How do you elevate the pharmacists to get embedded in the clinics and remain engaged? Granger, MD; Neha J.

Trials 130

Trials Cardiology Medicine Nurses 130

Rethinking Clinical Trials

AUGUST 4, 2022

TOGETHER, COVID-19, Peginterferon Lambda. TOGETHER is a randomized adaptive platform trial that was initiated in June 2020 to investigate the efficacy of repurposed treatments for COVID-19 disease among high-risk adult outpatients. It was a big treatment effect observed in a predominantly vaccinated population.

Trials 130

Trials Vaccination Vaccine Clinical Trials 130

The Pharma Data

MAY 4, 2021

to $3.65, Primarily Reflecting Updates to Anticipated Contributions from BNT162b2 Partially Offset by Additional R&D Expenses for Vaccines to Protect Against COVID-19 as Well as Other mRNA-Based Development Programs and COVID-19 Antivirals. Raises Full-Year 2021 Guidance (3) for Revenues to a Range of $70.5

Vaccination 40

Vaccination Vaccine Production Sales 40

Pharmaceutical Technology

NOVEMBER 30, 2022

The Health Survey for England 2019 reported that 28% of adults in the UK were obese and 36.2% Furthermore, an increase in a sedentary lifestyle, partly brought on by the Covid-19 pandemic, saw a further rise in the obese population. of adults were overweight, 42.4% Evaluate the effects of COVID-19 on the sector.

Drugs 264

Drugs Manufacturing Hormones Contract Manufacturing 264